These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 9758310

  • 1. Monoclonal antibodies in the treatment of steroid-resistant acute graft-versus-host disease.
    Tse JC, Moore TB.
    Pharmacotherapy; 1998; 18(5):988-1000. PubMed ID: 9758310
    [Abstract] [Full Text] [Related]

  • 2. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA.
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [Abstract] [Full Text] [Related]

  • 3. Treatment of steroid-resistant acute graft-versus-host disease with an anti-IL-2-receptor monoclonal antibody (BT 563) in children who received T cell-depleted, partially matched, related bone marrow transplants.
    Herbelin C, Stephan JL, Donadieu J, Le Deist F, Racadot E, Wijdenes J, Fischer A.
    Bone Marrow Transplant; 1994 May; 13(5):563-9. PubMed ID: 8054909
    [Abstract] [Full Text] [Related]

  • 4. Graft-versus-host disease in allogeneic bone marrow transplantation: the role of monoclonal antibodies in prevention and treatment.
    Hiscott A, McLellan DS.
    Br J Biomed Sci; 2000 May; 57(2):163-9. PubMed ID: 10912294
    [Abstract] [Full Text] [Related]

  • 5. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
    Russell CA, Heilmann C, Madsen HO, Vindeløv LL.
    Bone Marrow Transplant; 2001 May; 27(9):949-58. PubMed ID: 11436105
    [Abstract] [Full Text] [Related]

  • 6. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ, Chen HR, Wang HX, Yan HM, Liu J, Xue M, Zhu L.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
    [Abstract] [Full Text] [Related]

  • 7. Long-time survival after unrelated bone marrow transplantation in children and adolescents and targeted therapy with CD25 blockade to prevent GVHD.
    Wawer A, Laws HJ, Dilloo D, Göbel U, Burdach S.
    Klin Padiatr; 2004 Aug; 216(3):169-75. PubMed ID: 15175962
    [Abstract] [Full Text] [Related]

  • 8. Management of acute graft-versus-host disease.
    Deeg HJ, Henslee-Downey PJ.
    Bone Marrow Transplant; 1990 Jul; 6(1):1-8. PubMed ID: 2202460
    [Abstract] [Full Text] [Related]

  • 9. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H, Kitaori K, Kasai M, Shimokawa T, Kato C, Yamanishi H, Ueda R, Morishima Y.
    Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
    [Abstract] [Full Text] [Related]

  • 10. Blockade of acute grade IV skin and eye graft-versus-host disease by anti-interleukin-2 receptor monoclonal antibody in genoidentical bone marrow transplantation setting.
    Ozşahin H, Tuchschmid P, Lauener R, Waldvogel K, Nadal D, Seger RA.
    Turk J Pediatr; 1998 Jan; 40(2):231-5. PubMed ID: 9677728
    [Abstract] [Full Text] [Related]

  • 11. [Clinical trial of antithymocyte globulin for prophylaxis of acute graft-versus-host disease in pediatric recipients of bone marrow transplantation from unrelated donors].
    Yagasaki H, Kojima S, Inaba J, Kato K, Matsuyama T.
    Rinsho Ketsueki; 1999 May; 40(5):382-9. PubMed ID: 10390886
    [Abstract] [Full Text] [Related]

  • 12. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
    Michallet M, Perrin MC, Belhabri A, Molina L, Nicolini F, Tigaud JD, Sotto JJ, Guyotat D, Fière D, Archimbaud E.
    Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M, Khojasteh HN, Ramzi M, Haghshenas M.
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [Abstract] [Full Text] [Related]

  • 14. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F, Diyachenko G, Zabelina T, Panse J, Wolschke C, Eiermann T, Binder T, Fehse B, Erttmann R, Kabisch H, Bacher U, Kröger N, Zander AR.
    Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
    [Abstract] [Full Text] [Related]

  • 15. Prophylaxis and treatment of acute graft-versus-host disease: current state, implications of new immunopharmacologic compounds and future strategies to prevent and treat acute GVHD in high-risk patients.
    Deeg HJ.
    Bone Marrow Transplant; 1994 Aug; 14 Suppl 4():S56-60. PubMed ID: 7728127
    [Abstract] [Full Text] [Related]

  • 16. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C, Torres A, García-Castellano JM, Roman J, Martin C, Serrano J, Falcon M, Alvarez MA, Gomez P, Martinez F.
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An old drug for a new disease: pentostatin (Nipent) in acute graft-versus-host disease.
    Margolis J, Vogelsang G.
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):72-7. PubMed ID: 10877057
    [Abstract] [Full Text] [Related]

  • 19. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR.
    Biol Blood Marrow Transplant; 2001 Apr; 7(11):620-30. PubMed ID: 11760150
    [Abstract] [Full Text] [Related]

  • 20. Treatment of GVHD after blood transfusion.
    Sakuma H, Kikuta A, Suzuki H.
    Fukushima J Med Sci; 1993 Dec; 39(2):113-6. PubMed ID: 7927134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.